Skip to main content
. 2014 May 13;15(5):8473–8490. doi: 10.3390/ijms15058473

Figure 4.

Figure 4.

AtMYB44 competes with ABI1 for binding to RCAR1/PYL9 in vitro. His-RCAR1/PYL9 was pulled down with GST-AtMYB44 or GST in the absence or presence of His-ABI1 (or His). The gradient indicates increasing amount of His-ABI1. The immune-precipitated fractions were detected by western blotting with anti-His antibody (upper panel). GST-AtMYB44 input is shown in the lower panel. When indicated, the medium was supplemented with 10 μM ABA. Three independent experiments were performed and similar results were obtained.